These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8072721)

  • 21. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of antihypertensive therapy on the course of renal failure.
    Lederle RM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S69-72. PubMed ID: 1283193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Do angiotensin converting enzyme and calcium channel blocker intervene in the progression of renal disease besides by lowering systemic hypertension?].
    Nagase M
    Nihon Rinsho; 1997 Aug; 55(8):2116-22. PubMed ID: 9284433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
    Boner G; Cao Z; Cooper ME
    Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antihypertensive therapy on the progression of non-diabetic renal disease.
    Mann JF; Hilgers KF; Veelken R; Geiger H; Schmieder RE; Luft FC
    Clin Nephrol; 1992; 38 Suppl 1():S74-7. PubMed ID: 1295712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.
    Baba T; Neugebauer S; Watanabe T
    Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are calcium antagonists of value in ameliorating the course of chronic renal disease?
    Luft FC; Johnston CI
    Kidney Int Suppl; 1992 May; 36():S114-8. PubMed ID: 1614061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hypertension in renal disease.
    Ridao N; Luño J; García de Vinuesa S; Gómez F; Tejedor A; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():70-3. PubMed ID: 11369826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE-inhibitors in severe hypertension.
    Herlitz H
    Scand J Urol Nephrol Suppl; 1984; 79():73-9. PubMed ID: 6089321
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal effects of antihypertensive drugs.
    Schlueter WA; Batlle DC
    Drugs; 1989 Jun; 37(6):900-25. PubMed ID: 2667938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral diazoxide contraindicated in severe hypertension with renal failure.
    Mussche MM; De Broe ME; Belpaire FM; Vermeulen A; Ringoir SM
    Clin Nephrol; 1975; 4(3):99-103. PubMed ID: 810287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hypertension on the progression of chronic renal failure in children.
    Soergel M; Schaefer F
    Am J Hypertens; 2002 Feb; 15(2 Pt 2):53S-56S. PubMed ID: 11866231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.